Literature DB >> 20605986

Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype.

Erika I Lutter1, Christine Bonner, Martin J Holland, Robert J Suchland, Walter E Stamm, Travis J Jewett, Grant McClarty, Ted Hackstadt.   

Abstract

Chlamydia trachomatis is the leading cause of infectious blindness worldwide and is the most commonly reported pathogen causing sexually transmitted infections. Tarp (translocated actin recruiting phosphoprotein), a type III secreted effector that mediates actin nucleation, is central to C. trachomatis infection. The phylogenetic analysis of tarP from reference strains as well as ocular, genital, and lymphogranuloma venereum (LGV) clinical isolates demonstrated an evolutionary relationship with disease phenotype, with LGV and ocular isolates branched into clades that were separate from the urogenital isolates. The sequence analysis of Tarp indicated a high degree of variability and identified trends within clinical groupings. Tarps from LGV strains contained the highest number of tyrosine-rich repeat regions (up to nine) and the fewest (two) predicted actin binding domains. The converse was noted for Tarp proteins from ocular isolates that contained up to four actin binding domains and as few as one tyrosine-rich repeat region. The results suggest that Tarp is among the few known genes to play a role in C. trachomatis adaptations to specific niches within the host.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605986      PMCID: PMC2937449          DOI: 10.1128/IAI.00515-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  69 in total

1.  CLASSIFICATION OF TRACHOMA VIRUS STRAINS BY PROTECTION OF MICE FROM TOXIC DEATH.

Authors:  S P WANG; J T GRAYSTON
Journal:  J Immunol       Date:  1963-06       Impact factor: 5.422

2.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

Review 3.  Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal.

Authors:  Helen J Betts; Katerina Wolf; Kenneth A Fields
Journal:  Curr Opin Microbiol       Date:  2009-01-08       Impact factor: 7.934

4.  Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin.

Authors:  H Su; N G Watkins; Y X Zhang; H D Caldwell
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

Review 5.  Chlamydial infections (second of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

6.  Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism.

Authors:  João P Gomes; Alexandra Nunes; William J Bruno; Maria J Borrego; Carlos Florindo; Deborah Dean
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

7.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

Review 8.  New insights into Chlamydia intracellular survival mechanisms.

Authors:  Jordan L Cocchiaro; Raphael H Valdivia
Journal:  Cell Microbiol       Date:  2009-08-05       Impact factor: 3.715

9.  The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group.

Authors:  R C Brunham; J Kimani; J Bwayo; G Maitha; I Maclean; C Yang; C Shen; S Roman; N J Nagelkerke; M Cheang; F A Plummer
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

10.  Chlamydia trachomatis ompA variants in trachoma: what do they tell us?

Authors:  Aura A Andreasen; Matthew J Burton; Martin J Holland; Spencer Polley; Nkoyo Faal; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24
View more
  33 in total

Review 1.  Bacterial nucleators: actin' on actin.

Authors:  Joana N Bugalhão; Luís Jaime Mota; Irina S Franco
Journal:  Pathog Dis       Date:  2015-09-27       Impact factor: 3.166

Review 2.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

Review 3.  The alternative translational profile that underlies the immune-evasive state of persistence in Chlamydiaceae exploits differential tryptophan contents of the protein repertoire.

Authors:  Chien-Chi Lo; Gary Xie; Carol A Bonner; Roy A Jensen
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Chlamydia trachomatis Tarp cooperates with the Arp2/3 complex to increase the rate of actin polymerization.

Authors:  Shahanawaz Jiwani; Ryan J Ohr; Elizabeth R Fischer; Ted Hackstadt; Stephenie Alvarado; Adriana Romero; Travis J Jewett
Journal:  Biochem Biophys Res Commun       Date:  2012-03-23       Impact factor: 3.575

5.  Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways.

Authors:  Norma Olivares-Zavaleta; Aaron Carmody; Ronald Messer; William M Whitmire; Harlan D Caldwell
Journal:  J Immunol       Date:  2011-05-04       Impact factor: 5.422

6.  Polymorphisms in inc proteins and differential expression of inc genes among Chlamydia trachomatis strains correlate with invasiveness and tropism of lymphogranuloma venereum isolates.

Authors:  Filipe Almeida; Vítor Borges; Rita Ferreira; Maria José Borrego; João Paulo Gomes; Luís Jaime Mota
Journal:  J Bacteriol       Date:  2012-10-05       Impact factor: 3.490

7.  Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis.

Authors:  Chunxue Lu; Martin J Holland; Siqi Gong; Bo Peng; Robin L Bailey; David W Mabey; Yimou Wu; Guangming Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

Review 8.  Bacterial EPIYA effectors--where do they come from? What are they? Where are they going?

Authors:  Takeru Hayashi; Hiroko Morohashi; Masanori Hatakeyama
Journal:  Cell Microbiol       Date:  2012-11-01       Impact factor: 3.715

9.  Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L(2)) and D lineages.

Authors:  Naraporn Somboonna; Raymond Wan; David M Ojcius; Matthew A Pettengill; Sandeep J Joseph; Alexander Chang; Ray Hsu; Timothy D Read; Deborah Dean
Journal:  MBio       Date:  2011-05-03       Impact factor: 7.867

10.  Role for chlamydial inclusion membrane proteins in inclusion membrane structure and biogenesis.

Authors:  Jeffrey Mital; Natalie J Miller; David W Dorward; Cheryl A Dooley; Ted Hackstadt
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.